“Severe injection site reactions after subcutaneous administration of Sayana®: a retrospective, post-marketing analysis of WHO and Swiss spontaneous pharmacovigilance reports” (2017) Swiss Medical Weekly, 147(1920), p. w14432. doi:10.4414/smw.2017.14432.